Balancing the potential benefits and risks of any medication during pregnancy is crucial for the health and safety of both the mother and the developing baby
Demand is not a surrogate for safety. Verbois suggests that the PCACs evaluation and the FDAs ultimate decision on the seven peptides must account for how these products are being marketed and sold in the real world
So, the problem doesnt appear to be directly driven by hyperglycemia but possibly by other factors related to oxidative stress and inflammation two major culprits in chronic diseases like diabetes
Key Benefits Reduces HbA1c and improves blood sugar control Helps with weight loss in overweight/obese patients Convenient weekly dosing reduces treatment burden Cost-effective alternative to branded pens Safety & Usage Guidelines For subcutaneous injection only not IV or IM Inject once weekly in thigh, abdomen, or upper arm Requires regular monitoring of blood glucose, kidney function Use only as prescribed
Topical serums and creams can often be used in the morning, evening, or both
SELECT Trial - New England Journal of Medicine : The pivotal trial demonstrating 20% cardiovascular event reduction with semaglutide in people with obesity but without diabetes, establishing the cardioprotective effect independent of glucose-lowering
